Since IHC indicated that the SAS1B protein was translated at high incidence in primary uterine MMMTs, cell lines (SNU539 and S08-38710) derived from this tumor type were employed for subsequent experiments, while MAD10-252/616 was tested for SAS1B as a potential negative control. The gene discussed is ASTL; the disease is neoplasm.